A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system

by Shen, Yunbing, Jiang, Long, Iyer, Vaishnavi Srinivasan, Raposo, Bruno, Dubnovitsky, Anatoly, Boddul, Sanjaykumar V., Kasza, Zsolt, Wermeling, Fredrik
Published 2021

Designing custom CRISPR libraries for hypothesis-driven drug target discovery

by Iyer, Vaishnavi Srinivasan, Jiang, Long, Shen, Yunbing, Boddul, Sanjaykumar V., Panda, Sudeepta Kumar, Kasza, Zsolt, Schmierer, Bernhard, Wermeling, Fredrik
Published 2021

CRISPR/Cas9-induced DNA damage enriches for mutations in a p53-linked interactome: implications for CRISPR-based therapies

by Jiang, Long, Ingelshed, Katrine, Shen, Yunbing, Boddul, Sanjaykumar V., Iyer, Vaishnavi Srinivasan, Kasza, Zsolt, Sedimbi, Saikiran, Lane, David P., Wermeling, Fredrik
Published 2022

Modulating T-cell activation with antisense oligoucleotides targeting lymphocyte cytosolic protein 2

by Iyer, Vaishnavi Srinivasan, Boddul, Sanjaykumar V., Johnsson, Anna-Karin, Raposo, Bruno, Sharma, Ravi K., Shen, Yunbing, Kasza, Zsolt, Lim, Kah Wai, Chemin, Karine, Nilsson, Gunnar, Malmström, Vivianne, Phan, Anh Tuân, Wermeling, Fredrik
Published 2023